Search LD-1 & LD-2 Reports Registrations & Quarterly Activity
Loading...
| Registrant Name | Client Name | Report Type | Amount Reported |
Filing Year | Posted |
|---|---|---|---|---|---|
| GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC DBA HALEON | GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC DBA HALEON | Registration | 2022 | 01/05/2023 @ 09:22 AM | |
| GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC DBA HALEON | GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC DBA HALEON | 2nd Quarter - Report | $180,000.00 | 2023 | 07/20/2023 @ 07:49 AM |
| GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC DBA HALEON | GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC DBA HALEON | 3rd Quarter - Report | $190,000.00 | 2023 | 10/19/2023 @ 01:18 PM |
| GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC DBA HALEON | GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC DBA HALEON | 4th Quarter - Report | $120,000.00 | 2022 | 01/20/2023 @ 02:54 PM |
| GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC DBA HALEON | GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC DBA HALEON | 1st Quarter - Report | $140,000.00 | 2023 | 04/20/2023 @ 12:20 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,070,000.00 | 2016 | 07/20/2016 @ 04:23 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Registration - Amendment | 2002 | 04/03/2009 @ 03:39 PM | |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,240,000.00 | 2008 | 04/18/2008 @ 04:51 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,030,000.00 | 2023 | 10/20/2023 @ 04:19 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $2,000,000.00 | 2008 | 04/16/2009 @ 04:31 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $2,100,000.00 | 2009 | 10/21/2009 @ 09:14 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,210,000.00 | 2010 | 07/20/2010 @ 04:32 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $2,600,000.00 | 2009 | 01/20/2010 @ 02:43 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $1,020,000.00 | 2010 | 01/20/2011 @ 04:00 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Registration - Amendment | 2011 | 04/07/2011 @ 11:40 AM | |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $1,030,000.00 | 2011 | 01/19/2012 @ 03:11 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,510,000.00 | 2013 | 04/19/2013 @ 02:52 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,730,000.00 | 2015 | 04/15/2015 @ 10:45 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,123,000.00 | 2015 | 07/17/2015 @ 03:42 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,640,000.00 | 2017 | 04/20/2017 @ 10:30 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $780,000.00 | 2017 | 07/20/2017 @ 09:22 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $890,000.00 | 2012 | 10/18/2012 @ 01:55 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,630,000.00 | 2014 | 04/18/2014 @ 02:11 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Mid-Year Report | $1,500,000.00 | 2000 | 08/14/2000 @ 12:00 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Year-End Report | $1,200,000.00 | 1999 | 02/14/2000 @ 12:00 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Year-End Report | $1,627,000.00 | 2000 | 02/14/2001 @ 12:00 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Year-End Report | $2,900,000.00 | 2003 | 02/17/2004 @ 12:00 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Mid-Year Report | $2,000,000.00 | 2005 | 08/15/2005 @ 12:00 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Mid-Year Report | $1,600,000.00 | 2002 | 08/14/2002 @ 12:00 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Year-End Report | $2,600,000.00 | 2004 | 02/14/2005 @ 12:00 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Mid-Year Report | $2,300,000.00 | 2004 | 08/16/2004 @ 12:00 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Mid-Year Report | $1,740,000.00 | 2001 | 08/14/2001 @ 12:00 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Year-End Report | $2,260,000.00 | 2001 | 02/14/2002 @ 12:00 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Mid-Year Report | 2006 | 08/11/2006 @ 12:00 AM | |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Mid-Year Report | $3,620,000.00 | 2007 | 08/14/2007 @ 02:46 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Year-End Report | $2,860,000.00 | 2005 | 02/14/2006 @ 12:00 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Year-End Report | $2,500,000.00 | 2002 | 02/14/2003 @ 12:00 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,800,000.00 | 2008 | 07/21/2008 @ 04:19 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,950,000.00 | 2008 | 10/20/2008 @ 02:29 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $640,000.00 | 2016 | 10/20/2016 @ 06:32 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,390,000.00 | 2022 | 10/20/2022 @ 11:17 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $920,000.00 | 2018 | 01/22/2019 @ 06:07 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $1,370,000.00 | 2012 | 01/18/2013 @ 03:00 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $830,000.00 | 2022 | 04/20/2022 @ 06:37 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Amendment | $1,000,000.00 | 2021 | 10/21/2022 @ 11:47 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,800,000.00 | 2021 | 04/20/2021 @ 11:59 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Year-End Report | $4,620,000.00 | 2007 | 02/13/2008 @ 04:47 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,360,000.00 | 2019 | 10/21/2019 @ 04:53 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,140,000.00 | 2014 | 10/17/2014 @ 02:30 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Amendment | $1,100,000.00 | 2022 | 04/29/2022 @ 02:06 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,110,000.00 | 2022 | 07/20/2022 @ 05:19 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $520,000.00 | 2013 | 07/19/2013 @ 02:23 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $940,000.00 | 2020 | 04/20/2020 @ 09:52 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,765,000.00 | 2011 | 10/18/2011 @ 11:09 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,270,000.00 | 2013 | 10/18/2013 @ 04:24 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $2,120,000.00 | 2012 | 04/19/2012 @ 04:15 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $2,000,000.00 | 2008 | 01/16/2009 @ 03:37 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,600,000.00 | 2010 | 10/20/2010 @ 03:38 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Mid-Year Report | 2003 | 08/14/2003 @ 12:00 AM | |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $2,280,000.00 | 2009 | 07/20/2009 @ 07:26 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $420,000.00 | 2013 | 01/17/2014 @ 04:25 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,020,000.00 | 2014 | 07/18/2014 @ 11:57 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,400,000.00 | 2018 | 07/20/2018 @ 06:08 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,130,000.00 | 2018 | 10/22/2018 @ 05:47 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $870,000.00 | 2020 | 07/20/2020 @ 07:29 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,210,000.00 | 2020 | 10/20/2020 @ 08:04 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,490,000.00 | 2019 | 04/22/2019 @ 08:31 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,490,000.00 | 2016 | 04/20/2016 @ 07:19 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $870,000.00 | 2019 | 07/22/2019 @ 05:42 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $580,000.00 | 2014 | 01/16/2015 @ 04:39 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Amendment | $2,000,000.00 | 2008 | 04/23/2009 @ 09:47 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $842,000.00 | 2015 | 10/19/2015 @ 12:33 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $1,200,000.00 | 2021 | 10/20/2021 @ 05:02 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,220,000.00 | 2012 | 07/19/2012 @ 12:50 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $750,000.00 | 2020 | 01/20/2021 @ 09:50 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $1,110,000.00 | 2017 | 01/22/2018 @ 05:34 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,300,000.00 | 2021 | 07/20/2021 @ 01:27 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $700,000.00 | 2019 | 01/21/2020 @ 08:55 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | Mid-Year Report | $1,540,000.00 | 1999 | 08/16/1999 @ 12:00 AM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $900,000.00 | 2023 | 07/20/2023 @ 06:14 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $1,000,000.00 | 2021 | 01/20/2022 @ 07:17 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 3rd Quarter - Report | $650,000.00 | 2017 | 10/20/2017 @ 05:35 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,110,000.00 | 2018 | 04/20/2018 @ 04:32 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $2,240,000.00 | 2010 | 04/20/2010 @ 04:57 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,780,000.00 | 2009 | 04/20/2009 @ 04:30 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $380,000.00 | 2015 | 01/20/2016 @ 11:52 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,490,000.00 | 2011 | 04/20/2011 @ 02:09 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 2nd Quarter - Report | $1,160,000.00 | 2011 | 07/20/2011 @ 12:21 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Amendment | $1,440,000.00 | 2012 | 07/19/2012 @ 02:39 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $492,000.00 | 2016 | 01/23/2017 @ 07:51 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 4th Quarter - Report | $860,000.00 | 2022 | 01/20/2023 @ 03:16 PM |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | 1st Quarter - Report | $1,700,000.00 | 2023 | 04/20/2023 @ 10:38 PM |